Objective: A long-term follow-up of the OPAL trial to compare the effect of patient-initiated (PIFU) versus hospital-based (HBFU) follow-up on fear of cancer recurrence (FCR), quality of life (QoL) and healthcare use after 34 months of follow-up.
Design: Pragmatic, multicentre randomised trial.
Setting: Four Danish departments of gynaecology between May 2013 and May 2016.